Skip to content

Respiratory Decompensation and Model for the Triage of COVID-19 Patients

Prediction Of Respiratory Decompensation In Covid-19 Patients Using Machine Learning: The READY Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04390516
Acronym
READY
Enrollment
197
Registered
2020-05-15
Start date
2020-03-24
Completion date
2020-05-30
Last updated
2020-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus, COVID-19, Mechanical Ventilation, Mortality

Brief summary

The purpose of this study is to prospectively evaluate a machine learning algorithm for the prediction of outcomes in COVID-19 patients.

Detailed description

In a multi-center prospective clinical trial, a machine learning algorithm was deployed at five partner hospitals to analyze live patient data, including blood pressure and Creatinine levels, to determine the algorithm's ability to predict COVID-19 patient prognosis. The primary endpoint was mechanical ventilation of study subjects within 24 hours after hospital admission separate from a decompensation alert related to oxygen levels.

Interventions

DEVICECOViage

The COViage machine learning algorithm is designed to predict mechanical ventilation and mortality within 24 hours after hospital admission.

Sponsors

Dascena
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 years or older * Confirmed COVID-19 infection through RT-PCR test

Exclusion criteria

* Patients aged less than 18 years

Design outcomes

Primary

MeasureTime frameDescription
Mechanically ventilated patient outcomeThrough study completion, an average of 2 monthsVentilated or not ventilated within 24 hours

Secondary

MeasureTime frameDescription
Mortality or mechanically ventilated patient outcomeThrough study completion, an average of 2 monthsDeath or ventilated, or no death or not ventilated within 24 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026